DeciChat

Ask a question. Get an answer built from our own research.

Every answer comes from research DeciBio conducted: market reports, DxBooks datasets, and 250+ KOL interview transcripts. Ask in plain language, get one synthesized answer, and click through to the source behind any claim.

A living database, working for you

Ask the same question next month and see how the answer evolves.

DeciChat draws on a research base that keeps growing. New KOL interviews are added as we conduct them, DxBooks update as markets shift, and new reports join as they publish. So every answer reflects what we know today, not what we knew on a publication date.

Each new interview and dataset becomes one more source DeciChat can pull from. Ask, and it synthesizes what's current into a single answer, every piece cited.

An afternoon of manual cross-referencing, compressed into one query.
Q: What role does liquid biopsy play for therapy selection in 2026?
Therapy selection is now the most mature liquid biopsy application, with use strongest in advanced / metastatic disease and when "tissue is an issue", with growing acceptance of concurrent or reflex liquid biopsy testing, rather than replacing tissue outright. Lung cancer remains the anchor indication, supported by clearer guideline alignment and broad biomarker coverage, while expansion is extending into other solid tumors such as breast, ovarian, and prostate cancer. Newer therapetuic classes and novel genetic drivers are increasing the need for rapid patient-finding tools, and biopharma increasingly views LBx-based therapy selection as a "must-have" when tissue access is limited.
[1] Liquid Biopsy Market Report, 2026 [2] Oncology NGS DxBook [3–8] 6 KOL transcripts, H1 2026
every stage

From first evaluation to launch.

Scoping an opportunity, building the business case, pressure-testing it, then adjusting once you're in market. The questions change at every step. Where you ask them doesn't.

Competitive intelligence

A competitor announces a launch, a partnership, or a price cut, and leadership wants a read by Friday

  • DeciChat pulls what the reports, DxBooks, and KOL interviews already say about the competitor's position in minutes
  • You walk in with a sourced view of the landscape instead of an impression.
Ask a competitive question
How does [competitor]'s new NGS panel launch change the liquid biopsy competitive landscape?
Synthesized from 2 reports, 1 DxBook, 7 transcripts - cited.
Strategic planning

You're sizing an opportunity, and the board will want to push on the numbers

  • Market sizing and forecasts from the reports, adoption signals from KOLs interviewed as the market shifts
  • Every figure cited, so diligence questions have somewhere to go
Ask a planning question
What's the addressable market for MRD testing in 2028, and who's positioned to win?
Synthesized from 3 reports, 1 DxBook - cited.
Product launch

You're building the launch narrative, and the objections are already being raised

  • Transcript sentiment surfaces the real adoption barriers, in the field's own words
  • DxBook data shows where competing platforms are winning and why
Ask a launch question
What adoption barriers do pathologists flag for digital pathology in community settings?
Synthesized from 1 report, 1 DxBook, 9 transcripts - cited.
Before and after

What used to take an afternoon now takes one question

The research hasn't changed. Getting an answer out of it has.

Before

~ an afternoon per question
  • ×Three tabs, three searches: the report for the number, the transcripts for the field's read, the DxBook for the technology context
  • ×Then the by-hand part, copying findings into one narrative and hoping nothing contradicts
  • ×Whatever you didn't think to search, you didn't find
  • ×And by the time it's assembled, the meeting's moved on

With DeciChat

~ the time it takes to ask
  • One question searches all of it, including interviews added this week
  • The answer comes back synthesized, with citations attached
  • Every source gets searched, whether you thought of it or not
  • Ready while the question still matters

Bring us the question you're stuck on.

A live DeciChat session on the markets you compete in, answering the questions your team is working right now.

Request a demo

Bring us the question you're stuck on.

A live DeciChat session on the markets you compete in, answering the questions your team is working right now.

Bring us the question you're stuck on.

A live DeciChat session on the markets you compete in, answering the questions your team is working right now.